361 The prevalence of urinary incontinence in adult cystic fibrosis males  by unknown
Journal of Cystic Fibrosis 4 (2005) $96 S103 $97 
360* 
Comparison of the Modified Shuttle Test (MST) and 20m Shuttle Test 
in children with CF 
N. Cox l, J. Follett l, K. McKay 2, H. Selvadur ai 2 
Departments of PhysiotherapJ and Respiratory Medicine ~, The ChiMren's Hospital 
at Westmead 
BACKGROUND:  The choice of an appropriate field exercise test for children with 
CF is otlen been based on age or disease severity. The 20m shuttle t im test is 
generally used in older mad healthier chi ldren with CF, whi le  the 10m shuttle wa lk  
test is useful in either the very young or those with severe CF lung disease. The 
Modif ied 10m shuttle test (MST) incorporates aspects of both 10m and 20m sbuttle 
tests by al lowing subjects to wa lk  mad run. Due to the variety of f ield tests, 
longitudinal ssessment of peak aerobic capacity (VO~peak) has been l imited by an 
inability to compare outcomes obtained from the various tests. 
AIM: To compare the relationship between two of these tests the 20m shuttle and 
the MST in terms of peak aerobic capacity. 
METHOD:  35 children, with varying degrees of CF disease severity, completed 
both the 20m shuttle test and the MST within a 12 month period. 
RESULTS: Data from 35 children (12 male) aged 7.4 16 years (mean 11.4) was 
analysed. 20m shuttle performance mean (+ SE) was 3.55 levels (+ 0.27) and MST 
distance 865.7 m (+ 50.47 ). The difference in calculated VO2peak between the t sts, 
analysed via a Bland Al tman test, was mean 0.0003 ml/kg/min (l imits of agreement: 
1.5305, 1.5311 ml/kg/min). Significant correlations also exist between 20m sbuttle 
test level and (i) MST distance (r 0.865; p~).CO1); (ii) VO2peak calculated for the 
MST (r 0.865; p~).CO1), and (iii) FEV I% (r 0.44; p~).CO8). 
CONCLUSION: The results of this study have demonstrated a significant 
relationship between the calculated peak aerobic capacity for the 20m shuttle test 
mad MST. These results suggest that exercise capacity can be est imated 
longitudinally, regardless of disease severity, using the MST. 
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The relationship between pulmonary funcfion, and adherence in 
performing physiotherapy-a follow-up study 
M. Mcl lwaine,  T. Ha,  S. Wright, G. Davidson 
Cystic Fibrosis Clinic, BCChiMren's Hospital, Catuala 
We have previously reported the results of a study examining the effects of non 
adherence of 92 CF patients in performing their physiotherapy regimen. In that 
study, the mean overall rate of decl ine in FEV l was 1.44% per year. In the group 
of 13 non adherent patients, FEV l declined at 2.62% per year (p~).01). ha this 
follow up study, 11 of the non adherent patients who had participated in the 
previous study were enrolled. Each patient was interviewed as to the reasons for 
non adherence. Major  issues were  psycho social, and the perception that 
physiotherapy was of little benefit o them. Intervention consisted of counsell ing by 
the CF team and close monitoring by frequent follow ups at the CF clinic. At  the 
end of a one year period, adherence l vels were again evaluated. Results are based 
on 10 patients (1 patient lost to fol low up). Of  these 10 patients, 4 patients (mean 
age 12.2 years) improved their adherence l vel to physiotherapy to a mean of 89%. 
6 patients (mean age 15.0 years) remained non adherent to physiotherapy with an 
adherence level between 030%.  When we examined the health outcomes of these 
two groups, there were significant differences, ha the group who became adherent, 
there was a reversal of the decl ine in FEV l from the previous year to a +7% rate of 
change per year. In the group who remained non adherent, FEV l continued to 
decl ine at a mean rate 2.83% per year. In this group there were 8 hospitalizations 
for respiratory problems as compared to 1 hospitalization i the adherent group. 
From this study we conclude that it is possible for patients to improve adherence 
and this is associated with positive health outcomes. Greater success is achieved by 
addressing non adherence ha the younger patients before teenage issues compound 
the problem. 
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The prevalence of urinary incontinence in adult cysfic fibrosis males 
L. Gumery, J. Lee, J. Whitebouse, D. Honeybounae 
West Midla~uls Adult CF Centre, Birmingham Heartla~uls and SolihulI NHS Trust, 
UK 
Aims This study investigated urinary incontinence (UI) prevalence in adult cystic 
fibrosis (CF) males, after implementat ion of recommendations to improve 
identification, diagnosis and treatment. The recommendations aimed to enhance 
education, staff/patient awareness, establish open dialogue and sensitively question 
men at annual review/ongoing assessment, leading to urology/specialist continence 
physiotherapy referral. 
Methods 129 adult CF males were surveyed via self administered confidential 
postal queslionnaire. Eleven closed questions related to cause, severity and impact 
of UI. Clinical data collected included age mad CF lung disease severity (based on 
percentage predicted spit ometry). 
Results 79% (102/129) males (age range 18 50 years) responded. UI  prevalence 
was 16% (16/102) higher than any previous research. UI  increased with both age 
and lung disease severity, however, this was not statistically significant. Those with 
severe lung disease had a two fold r isk of UI compared to mild/moderate disease 
(RR 2.31 95% CI (0.95 5.64) (Fishers exact 2 tailed test p 0.09), which was not 
significant. The major causes of UI  were coughing, ACI', spirometry and a full 
bladder, which affected ability to perform AC~I" 10% (11/102) and spirometry 9% 
(10/102). UI  c¢curred in 88 % (14/16) at any t ime and ha 12% (2/16), only when the 
chest was 'bad'. Overall, UI distressed 81% (13/16) yet few, 12% (2/16) had 
previously sought help due to 'embmrassment'. Fol low up was now requested by a 
further 44% (7/16). 
Conclusion This study identified an increased two fold r isk of developing UI  in 
those with severe CF lung disease and a higher than previously reported prevalence 
of 16% in adult CF males, after implementation of continence recommendations. 
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Timing of nebulisation of rhDNase and airway clearance techniques 
(ACT) in children with Cysfic Fibrosis 
L.J. van der Giessen l, R. Gosselink ~, J.C. de Jongste 3, W.CJ.  Hop 4, H.A.W.M. 
Tiddens  
~Department of Paediatric Physiotherapy, Erasmus MC Sophia Rotterdam, The 
Netherlands, 2Department of Pulmonary Rehabil#ation, University Hospital 
Leuvetg Belgium, SDepartment of Paediatrics Respiratory Medicine and 
AIIergology, Erasmus MC Sophia Rotterdam, The Netherlands, 4Department of 
Epidemiology and Biostatistics, Erasmus MC Rotterdar~ The Netherlatuls 
Background:  Though the effectiveness of rlf l)Nase is wel l  established, little 
research has been cmried out to determine the optimal t ime relation between 
rlf l)Nase and ACT. 
Objective: To assess the difference in lung function between nebulisation of 
rlf l)Nase before AC~I" versus nebulisation after ACT. 
Methods:  Placebo controlled randomised cross over trial. Inclusion criteria were 
CF, stable cl inical condition and rlf l)Nase maintenance therapy. Randomization: 
Group I: Week 1 3, inhalation of rlf l)Nase 30 minutes before, and placebo directly 
after ACT. Week 4 6 the reversed protc~ol. Group II: Reversed sequence. Patients 
continued their dai ly routine ACT. Primary end point: MEF~>. Flow volume 
maneuver and R in t  were measured on day 0, 14, 21, 35 and 42. Cough and sputum 
production were scored daily on diary cards by the children ha week 3 and 6. 
Results:  24 patients completed the study. MEF~> was 6% higher (p~),01) at the end 
of 3 ~d week when rlf l)Nase was nebulized after ACT compared to nebulisation 
before. There was a trend towards a greater effect for children with higher MEF~> at 
the start of study (p 0,07) and a trend (p~),06) for more night t ime coughs when 
rbDNase was used after ACT. No significant changes between treatment arms for 
FVC, FEVI, R INT  mad diary scores were found. 
Conclusion: MEF~> improves more when rhDNase is inhaled dkectly after AC~I" 
rather than before. 
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